186 related articles for article (PubMed ID: 20403392)
1. Neurotensin modulates central muscarinic receptors, an effect which does not involve the high-affinity neurotensin receptor (NTS1).
Schneider PG; López Ordieres MG; Rodríguez de Lores Arnaiz G
Regul Pept; 2010 Aug; 163(1-3):37-42. PubMed ID: 20403392
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin decreases high affinity [3H]-ouabain binding to cerebral cortex membranes.
Rosin C; Ordieres MG; Arnaiz GR
Regul Pept; 2011 Dec; 172(1-3):35-40. PubMed ID: 21896291
[TBL] [Abstract][Full Text] [Related]
3. High-affinity neurotensin receptor is involved in phosphoinositide hydrolysis stimulation by carbachol in neonatal rat brain.
Pereyra-Alfonso S; López Ordieres MG; del V Armanino M; de Lores Arnaiz GR
Brain Res Dev Brain Res; 2005 Feb; 154(2):247-54. PubMed ID: 15707678
[TBL] [Abstract][Full Text] [Related]
4. The role of neurotensin in positive reinforcement in the rat central nucleus of amygdala.
László K; Tóth K; Kertes E; Péczely L; Lénárd L
Behav Brain Res; 2010 Apr; 208(2):430-5. PubMed ID: 20035801
[TBL] [Abstract][Full Text] [Related]
5. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
6. The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.
Gutnisky A; López Ordieres MG; Rodríguez de Lores Arnaiz G
Neurochem Res; 2016 Jun; 41(6):1274-80. PubMed ID: 26738992
[TBL] [Abstract][Full Text] [Related]
7. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
9. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
10. Effect of the nonpeptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea pig ileum and colon.
Labbé-Jullié C; Deschaintres S; Gully D; Le Fur G; Kitabgi P
J Pharmacol Exp Ther; 1994 Oct; 271(1):267-76. PubMed ID: 7965724
[TBL] [Abstract][Full Text] [Related]
11. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
Martin MW; Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
[TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
13. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin.
Scarcériaux V; Souazé F; Bachelet CM; Forgez P; Bourdel E; Martinez J; Rostène W; Pélaprat D
J Neuroendocrinol; 1996 Aug; 8(8):587-93. PubMed ID: 8866245
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
[TBL] [Abstract][Full Text] [Related]
17. Changes in [
Rosin C; López Ordieres MG; Rodríguez de Lores Arnaiz G
Peptides; 2017 Mar; 89():82-89. PubMed ID: 27586561
[TBL] [Abstract][Full Text] [Related]
18. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
19. The role of neurotensin in passive avoidance learning in the rat central nucleus of amygdala.
László K; Tóth K; Kertes E; Péczely L; Ollmann T; Madarassy-Szücs A; Lénárd L
Behav Brain Res; 2012 Jan; 226(2):597-600. PubMed ID: 21946307
[TBL] [Abstract][Full Text] [Related]
20. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
